Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)
| 0.61 Delayed Data As of 1:22pm ET |  -0.0419 / -6.43%Today’s Change | 0.53 Today|||52-Week Range 3.38 | -8.55% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -14.3M | -11.8M | -7.5M | -7.3M | |
| Depreciation | 210.0K | 133.0K | 32.0K | 29.0K | ||
| Total Other Cash Flow | 796.0K | 770.0K | 266.0K | 331.0K | ||
| Funds From Operations | -13.3M | -10.9M | -7.2M | -6.9M | ||
| Funds From/For Other Operating Expenses | 1.1M | -809.0K | 308.0K | -227.0K | ||
| Net Cash Flow - Operating Activities | -14.5M | -10.1M | -7.5M | -6.7M | ||
| Investing | Capital Expenditures | -34.0K | -3.0K | -13.0K | -39.0K | |
| Fixed Asset Disposal | -- | 12.0K | 0.00 | -- | ||
| Other Investing - Sources | 96.0K | 0.00 | 0.00 | 0.00 | ||
| Net Cash Flow Investing | 62.0K | 9.0K | -13.0K | -39.0K | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 11.1M | 6.8M | 14.9M | 630.0K | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | -201.0K | -200.0K | -201.0K | -201.0K | ||
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 10.9M | 6.6M | 14.7M | 429.0K | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -211.0K | -444.0K | 135.0K | -95.0K | |
| Net Change In Cash | -3.5M | -3.5M | 7.3M | -6.3M | ||
